Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Crown offer of $3.65 per share is the only offer available to Revance stockholdersCrown offer unanimously approved by the Revance Board of DirectorsTeoxane withdraws its previous proposal, says it will